Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M LEBEL

Showing results (51-60 of 187) with videos related to

Pageof 19
Sort By:
Drug Intelligence & Clinical Pharmacy|December 1, 1985
Serum bactericidal activity of ceftazidime increased by netilmicinM LeBel, M Pellerin, M G Bergeron
Antimicrobial Agents and Chemotherapy|June 1, 1990
Safety of fleroxacin coadministered with theophylline to young and elderly volunteersM Parent, M St-Laurent, M LeBel
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 1, 1989
Modulation of renal hemodynamics by renal eicosanoids during vasopressor infusions in manM Lebel, J H Grose, P Falardeau
The American Journal of Surgical Pathology|August 1, 1988
Renin-producing ovarian tumor. A case report with immunohistochemical and electron-microscopic studyB Têtu, M Lebel, J P Camilleri
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1989
Increased hematocrit with normal red blood cell mass in early borderline essential hypertensionM Lebel, J H Grose, R Blais
American Journal of Hypertension|September 1, 1991
Effect of short-term administration of cromakalim on renal hemodynamics and eicosanoid excretion in essential hypertensionM Lebel, J H Grose, Y Lacourcière
Antimicrobial Agents and Chemotherapy|June 1, 1990
Influence of lomefloxacin on the pharmacokinetics of theophyllineM LeBel, F Vallée, M St-Laurent
Clinical and Experimental Hypertension|January 1, 1981
Alteration of the volume-renin component in borderline essential hypertensionM Lebel, J H Grose, R Blais
Cancer Research|March 31, 2001
Tumorigenic effect of nonfunctional p53 or p21 in mice mutant in the Werner syndrome helicaseM Lebel, R D Cardiff, P Leder
American Journal of Hypertension|April 1, 1989
Short-term monotherapy with the potassium channel activator BRL 34915 on endocrine sodium regulation in essential hypertensionM Lebel, J H Grose, Y Lacourcière
Pageof 19

Showing results (51-60 of 187) with videos related to

Sort By:
Pageof 19
Drug Intelligence & Clinical Pharmacy|December 1, 1985
Serum bactericidal activity of ceftazidime increased by netilmicinM LeBel, M Pellerin, M G Bergeron
Antimicrobial Agents and Chemotherapy|June 1, 1990
Safety of fleroxacin coadministered with theophylline to young and elderly volunteersM Parent, M St-Laurent, M LeBel
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 1, 1989
Modulation of renal hemodynamics by renal eicosanoids during vasopressor infusions in manM Lebel, J H Grose, P Falardeau
The American Journal of Surgical Pathology|August 1, 1988
Renin-producing ovarian tumor. A case report with immunohistochemical and electron-microscopic studyB Têtu, M Lebel, J P Camilleri
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1989
Increased hematocrit with normal red blood cell mass in early borderline essential hypertensionM Lebel, J H Grose, R Blais
American Journal of Hypertension|September 1, 1991
Effect of short-term administration of cromakalim on renal hemodynamics and eicosanoid excretion in essential hypertensionM Lebel, J H Grose, Y Lacourcière
Antimicrobial Agents and Chemotherapy|June 1, 1990
Influence of lomefloxacin on the pharmacokinetics of theophyllineM LeBel, F Vallée, M St-Laurent
Clinical and Experimental Hypertension|January 1, 1981
Alteration of the volume-renin component in borderline essential hypertensionM Lebel, J H Grose, R Blais
Cancer Research|March 31, 2001
Tumorigenic effect of nonfunctional p53 or p21 in mice mutant in the Werner syndrome helicaseM Lebel, R D Cardiff, P Leder
American Journal of Hypertension|April 1, 1989
Short-term monotherapy with the potassium channel activator BRL 34915 on endocrine sodium regulation in essential hypertensionM Lebel, J H Grose, Y Lacourcière
Pageof 19